Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura Yang
Institution:
University Hospitals Sussex NHS Foundation Trust
Observed institution:
University Hospitals Sussex NHS Foundation Trust
ORCID:
0009-0002-2937-6354
Observed ORCID:
0009-0002-2937-6354
OpenAlex ID:
A5086129249
Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World Dataset
2022
·
Faouzi Djebbari
, Alexandros Rampotas
, et al.
·
HemaSphere
·
14
Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study
2022
·
Faouzi Djebbari
, Alexandros Rampotas
, et al.
·
Hematology
·
6
PDF
Evaluation of Palliative Care Related Hospital Admissions in a Regional Centre
2023
·
Laura Yang
, Charlie Hollis
, et al.
·
American Journal of Hospice and Palliative Medicine®
·
3
Isatuximab with Pomalidomide and Dexamethasone Provides Comparable Efficacy Outcomes in Frail Routine Care Myeloma Patients in a UK-Wide Cohort
2022
·
Alexandros Rampotas
, Alexandros Rampotas
, et al.
·
Blood
·
1
Efficacy Outcomes of Isatuximab with Pomalidomide and Dexamethasone Are Comparable to (ICARIA-MM) Trial Data: Initial Results of a UK-Wide Real-World Study of Relapsed Myeloma Patients
2021
·
Faouzi Djebbari
, Grant Vallance
, et al.
·
Blood
·
1
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK ‐wide real‐world cohort of relapsed myeloma patients
2023
·
Faouzi Djebbari
, Alexandros Rampotas
, et al.
·
British Journal of Haematology
PDF
Show more works
View as search
Works count:
6
Citation count:
25
H-index:
3
I10-index:
1
Year
Topic
Type